The FDA approved Tudriqev, an engineered herpes virus injected into melanoma tumors, for patients whose disease progressed on PD-1 immunotherapy.
A Modified Herpes Virus Injected into Tumors Wins FDA Approval for Advanced Melanoma
by | Aug 11, 2026 | Uncategorized | 0 comments
Recent Comments